1. Home
  2. CRGX vs FRAF Comparison

CRGX vs FRAF Comparison

Compare CRGX & FRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • FRAF
  • Stock Information
  • Founded
  • CRGX 2021
  • FRAF 1906
  • Country
  • CRGX United States
  • FRAF United States
  • Employees
  • CRGX N/A
  • FRAF N/A
  • Industry
  • CRGX
  • FRAF Major Banks
  • Sector
  • CRGX
  • FRAF Finance
  • Exchange
  • CRGX Nasdaq
  • FRAF Nasdaq
  • Market Cap
  • CRGX 180.4M
  • FRAF 165.3M
  • IPO Year
  • CRGX 2023
  • FRAF N/A
  • Fundamental
  • Price
  • CRGX $4.64
  • FRAF $37.30
  • Analyst Decision
  • CRGX Hold
  • FRAF
  • Analyst Count
  • CRGX 7
  • FRAF 0
  • Target Price
  • CRGX $4.67
  • FRAF N/A
  • AVG Volume (30 Days)
  • CRGX 653.7K
  • FRAF 21.4K
  • Earning Date
  • CRGX 05-13-2025
  • FRAF 04-29-2025
  • Dividend Yield
  • CRGX N/A
  • FRAF 3.55%
  • EPS Growth
  • CRGX N/A
  • FRAF N/A
  • EPS
  • CRGX N/A
  • FRAF 2.51
  • Revenue
  • CRGX N/A
  • FRAF $69,210,000.00
  • Revenue This Year
  • CRGX $58.18
  • FRAF N/A
  • Revenue Next Year
  • CRGX N/A
  • FRAF N/A
  • P/E Ratio
  • CRGX N/A
  • FRAF $14.86
  • Revenue Growth
  • CRGX N/A
  • FRAF 5.24
  • 52 Week Low
  • CRGX $3.00
  • FRAF $25.83
  • 52 Week High
  • CRGX $25.45
  • FRAF $38.41
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 59.08
  • FRAF 63.51
  • Support Level
  • CRGX $3.58
  • FRAF $33.96
  • Resistance Level
  • CRGX $4.17
  • FRAF $35.20
  • Average True Range (ATR)
  • CRGX 0.26
  • FRAF 1.07
  • MACD
  • CRGX 0.12
  • FRAF 0.24
  • Stochastic Oscillator
  • CRGX 92.98
  • FRAF 98.00

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About FRAF Franklin Financial Services Corporation

Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals, and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.

Share on Social Networks: